Avexa up 45% today after exceptional results from its Phase 2b trials. Phase 3 results to come in next quarter. Might have been a good partner to join forces with after all. Good luck to the PGL holders. Could have been a win-win.
PGL Price at posting:
77.7¢ Sentiment: Sell Disclosure: Held